Assembly Biosciences, Inc.ASMBNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank79
3Y CAGR+39.7%
5Y CAGR+9.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+39.7%/yr
vs -30.5%/yr prior
5Y CAGR
+9.9%/yr
Recent acceleration
Acceleration
+70.3pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $68.30M | -7.6% |
| 2024 | $73.94M | +222.8% |
| 2023 | $22.91M | -8.5% |
| 2022 | $25.03M | -82.0% |
| 2021 | $138.94M | +226.6% |
| 2020 | $42.54M | +27.6% |
| 2019 | $33.35M | -69.0% |
| 2018 | $107.54M | +75.6% |
| 2017 | $61.25M | +35.3% |
| 2016 | $45.28M | - |